DP58 Inhibitors
DP58 inhibitors are a class of chemical compounds that specifically target and inhibit the function of DP58, a protein potentially involved in regulatory or signaling pathways within the cell. While DP58 may not be extensively characterized in widely available literature, its naming suggests a role in a critical cellular function, possibly linked to intracellular communication, protein interactions, or transcriptional regulation. Proteins like DP58 may influence a variety of cellular processes, including gene expression, signal transduction, and cellular growth. By inhibiting DP58, researchers can explore how this protein contributes to these processes and the impact its regulation has on overall cellular dynamics and homeostasis.
The mechanism of DP58 inhibitors typically involves binding to functional domains of the protein that are essential for its activity. These inhibitors may interfere with DP58's ability to interact with other proteins or block its participation in key biochemical pathways. Structurally, DP58 inhibitors are designed to either mimic the natural substrates or binding partners of the protein or to interact with specific regions that are critical for its conformation and function. By disrupting these interactions, DP58 inhibitors prevent the protein from carrying out its normal biological roles, enabling researchers to study the effects of its inhibition on cellular signaling, protein interactions, or other pathways. The study of DP58 inhibitors provides valuable insights into the molecular mechanisms that regulate cellular processes, contributing to a deeper understanding of how specific proteins like DP58 influence complex networks of cellular functions.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent kinase inhibitor that disrupts multiple signaling pathways. By inhibiting kinases, it can lead to the dephosphorylation and inactivation of DP58, which may require phosphorylation for full activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that can downregulate protein synthesis. As mTOR is a key regulator of cell growth, its inhibition can lead to decreased availability of components necessary for DP58 function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that prevents the phosphorylation of AKT. Since DP58 function may be modulated by AKT signaling, inhibition of this pathway can lead to reduced DP58 activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
By inhibiting MEK, which is upstream of ERK in the MAPK pathway, this compound can decrease the activation of transcription factors that could be essential for DP58 expression and function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor which may reduce the phosphorylation of substrates involved in stress responses, potentially diminishing the functional activity of DP58 if it is involved in these pathways. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, which is part of the MAPK pathway. Inhibiting JNK can alter the cellular response to stress and cytokines, potentially leading to decreased DP58 activity if it is implicated in these responses. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that can lead to the accumulation of misfolded proteins, inducing stress responses that might downregulate DP58 if it is sensitive to cellular stress signals. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A PI3K inhibitor that prevents the activation of AKT. Inhibition of this pathway can lead to decreased DP58 activity if DP58 is regulated by AKT-mediated signaling. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
This compound inhibits MEK1/2, leading to decreased ERK phosphorylation and potentially impacting DP58 activity if DP58 is downstream of ERK signaling. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
An Aurora kinase inhibitor that disrupts mitotic spindle assembly and chromosome alignment. This could indirectly inhibit DP58 if it is involved in cell cycle regulation. | ||||||